Hand Sanitizers Raise OTC Profile In US FDA’s Latest Drug Manufacturing Quality Report
Widespread problems FDA found in hand sanitizers resulted from businesses unfamiliar with drug production entering the space after agency eased manufacturing standards to encourage increased supplies. Heartburn remedy ranitidine noted due to its chemical profile, not errors by manufacturers.
You may also be interested in...
FDA advised Chinese firm Max-Lux Corp. that its Safe-T-Lite UV Wand was found in a July 2020 evaluation to be unsafe due to the absence of instructions for use. Typical use could expose consumers to unsafe levels of electronic product radiation.
A day after FDA posted Scentsational’s recall announcement due to presence of benzene and acetaldehyde as well as methanol, American Cleaning Institute and Consumer Healthcare Products Association submit a letter urging FDA to restore order to OTC alcohol-based sanitizer market.
Revision to FDA's September 2020 guidance on assessing nitrosamine impurity risks associated with all chemically synthesized APIs and all approved drug products that contain those APIs doesn’t satisfy industry stakeholders.